Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from DocMorris ( (CH:DOCM) ) is now available.
Pelion S.A., the largest healthcare company in Poland, has acquired a 9.68% stake in DocMorris AG, marking a significant strategic investment in the Swiss-based online pharmacy and healthcare marketplace. This participation by Pelion, which is active in multiple European countries, is expected to bolster DocMorris’s industry positioning and expand its market influence, particularly given Pelion’s extensive experience in the pharmacy business.
The most recent analyst rating on (CH:DOCM) stock is a Sell with a CHF19.00 price target. To see the full list of analyst forecasts on DocMorris stock, see the CH:DOCM Stock Forecast page.
More about DocMorris
DocMorris AG is a leading company in the online pharmacy, marketplace, and professional healthcare sectors, with a strong presence in Germany and other European countries. The company operates a highly automated logistics center in the Netherlands and has a significant market presence in Southern Europe, particularly in Spain and France. In 2024, DocMorris achieved external sales of CHF 1,085 million with over 10 million active customers across several European countries.
Average Trading Volume: 344,127
Current Market Cap: CHF449M
For an in-depth examination of DOCM stock, go to TipRanks’ Stock Analysis page.